CytomX Therapeutics (CTMX) Receivables - Other (2015 - 2026)

CytomX Therapeutics (CTMX) posted Receivables - Other of $1.5 million for Q1 2026, up 200.0% on a QoQ basis from $500000.0 in Q4 2025.

CytomX Therapeutics (CTMX) Receivables - Other (2015 - 2026) Analysis & Trends

CytomX Therapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $1.5 million for Q1 2026.

  • Quarterly Receivables - Other changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY) and the FY2025 annual result came in at $500000.0, up 2172.73% from the prior year.
  • Receivables - Other was $1.5 million for Q1 2026 at CytomX Therapeutics, up from $500000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.5 million in Q1 2026 and bottomed at $22000.0 in Q4 2024.
  • A 3-year average of $674000.0 and a median of $500000.0 in 2025 frame the typical range for Receivables - Other.
  • Peak annual rise in Receivables - Other reached 2172.73% in 2025, while the deepest fall reached 2172.73% in 2025.
  • CytomX Therapeutics' Receivables - Other stood at $22000.0 in 2024, then surged by 2172.73% to $500000.0 in 2025, then jumped by 200.0% to $1.5 million in 2026.
  • Business Quant data shows CTMX's Receivables - Other at $1.5 million in Q1 2026, $500000.0 in Q4 2025, and $22000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 CytomX Therapeutics 590.32 Mn 243.61 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.50 Mn
Mar 31, 2026 1.50 Mn
Dec 31, 2025 500,000.00
Dec 31, 2025 500,000.00
Dec 31, 2024 22,000.00
Dec 31, 2024 22,000.00
Sep 30, 2017 68,000.00
Sep 30, 2017 68,000.00
Jun 30, 2017 27,000.00
Jun 30, 2017 27,000.00
Mar 31, 2017 55,000.00
Mar 31, 2017 55,000.00
Dec 31, 2016 154,000.00
Dec 31, 2016 154,000.00
Sep 30, 2016 207,000.00
Sep 30, 2016 207,000.00
Jun 30, 2016 113,000.00
Jun 30, 2016 113,000.00
Mar 31, 2016 158,000.00
Mar 31, 2016 158,000.00